What is Aclaris Therapeutics, Inc.'s Market Cap?

Aclaris Therapeutics, Inc.'s Market Cap is $805.9M, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s Enterprise Value?

Aclaris Therapeutics, Inc.'s Enterprise Value is $786.8M, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s Price / Sales?

Aclaris Therapeutics, Inc.'s Price / Sales is 98.1×, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s EV / Revenue?

Aclaris Therapeutics, Inc.'s EV / Revenue is 95.7×, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s EV / EBITDA?

Aclaris Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s Revenue (TTM)?

Aclaris Therapeutics, Inc.'s Revenue (TTM) is $8.2M, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s Net Income (TTM)?

Aclaris Therapeutics, Inc.'s Net Income (TTM) is -$75.7M, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s EBITDA?

Aclaris Therapeutics, Inc.'s EBITDA is -$85.9M, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s Diluted EPS (TTM)?

Aclaris Therapeutics, Inc.'s Diluted EPS (TTM) is -0.51, based on as-reported figures from SEC (XBRL) filings.

What is Aclaris Therapeutics, Inc.'s EBITDA Margin?

Aclaris Therapeutics, Inc.'s EBITDA Margin is -1045.0%, based on as-reported figures from SEC (XBRL) filings.

Aclaris Therapeutics, Inc. (ACRS) Financial Statements

Aclaris Therapeutics, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG003LF0QS8

XNAS · usd

5.48▼ 0.58 (-9.65%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close6.06

Day's Range5.92 – 6.15

52-Week Range1.74 – 6.60

Volume3.1M

Avg Volume1.8M

Share Statistics

Shares Outstanding

Employees73

ExchangeXNAS

Listed2015-10-07

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Aclaris Therapeutics, Inc. (ACRS)

What is Aclaris Therapeutics, Inc.'s Market Cap?: Aclaris Therapeutics, Inc.'s Market Cap is $805.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s Enterprise Value?: Aclaris Therapeutics, Inc.'s Enterprise Value is $786.8M, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s Price / Sales?: Aclaris Therapeutics, Inc.'s Price / Sales is 98.1×, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s EV / Revenue?: Aclaris Therapeutics, Inc.'s EV / Revenue is 95.7×, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s EV / EBITDA?: Aclaris Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s Revenue (TTM)?: Aclaris Therapeutics, Inc.'s Revenue (TTM) is $8.2M, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s Net Income (TTM)?: Aclaris Therapeutics, Inc.'s Net Income (TTM) is -$75.7M, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s EBITDA?: Aclaris Therapeutics, Inc.'s EBITDA is -$85.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s Diluted EPS (TTM)?: Aclaris Therapeutics, Inc.'s Diluted EPS (TTM) is -0.51, based on as-reported figures from SEC (XBRL) filings.
What is Aclaris Therapeutics, Inc.'s EBITDA Margin?: Aclaris Therapeutics, Inc.'s EBITDA Margin is -1045.0%, based on as-reported figures from SEC (XBRL) filings.